VSee Health, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $1.6M
- Price
- $1.93
- % Change (Daily % change from the live per-ticker quote feed.)
- +21.23%
- Volume
- 1.7K
About
VSee Health, Inc. specializes in delivering virtual healthcare solutions. Their flagship offering, iDoc Telehealth, is specifically designed to manage and coordinate comprehensive care for severely ill individuals within various critical care environments, including neurointensive, cardiac intensive, and general intensive care units (ICUs). This system addresses complex conditions such as stroke, spinal cord injuries, brain trauma, and other severe neurological disorders. Beyond specialized care, their broader telehealth platform provides a modular suite of digital tools, empowering clients to customize solutions to their unique needs. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Quick stats
Quick-stats data pending — refreshes nightly.
Key info
SectorHealthcare
IndustryMedical - Healthcare Information Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001864531
Websitehttps://www.vseehealth.com
AI Summary
AI-generated1/31
minorneutraloperations update
VSee Health Shareholder Letter
VSee Health CEO Dr. Imoigele Aisiku issued a shareholder letter confirming the company's NASDAQ delisting and describing a strategic refocus on iDoc, its hospital-focused telehealth business.
The letter cites growth into 58 hospitals and says revenue from continuing operations grew in the first half of 2026, though no specific figures are disclosed.
The 2027 plan targets roughly doubling annual revenue with a path to profitability, while the company works toward an OTCQB move and evaluates M&A, partnerships, and financing alternatives.
Red flags
- recently delisted from NASDAQ; shares moving to OTCQB with lower liquidity and visibility
- 2027 revenue-doubling target provided without supporting figures or baseline disclosure
- letter references possible M&A and financing alternatives -- potential future dilution or strategic-transaction uncertainty